A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain

Nanoparticle-mediated drug delivery is especially useful for targets within endosomes because of the endosomal transport mechanisms of many nanomedicines within cells. Here, we report the design of a pH-responsive, soft polymeric nanoparticle for the targeting of acidified endosomes to precisely inhibit endosomal signalling events leading to chronic pain. In chronic pain, the substance P (SP) neurokinin 1 receptor (NK1R) redistributes from the plasma membrane to acidified endosomes, where it signals to maintain pain. Therefore, the NK1R in endosomes provides an important target for pain relief. The pH-responsive nanoparticles enter cells by clathrin- and dynamin-dependent endocytosis and accumulate in NK1R-containing endosomes. Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission. Treatment with the nanoparticles leads to complete and persistent relief from nociceptive, inflammatory and neuropathic nociception and offers a much-needed non-opioid treatment option for chronic pain.A pH-responsive, soft polymeric nanoparticle targets the neurokinin 1 receptor in acidified endosomes to inhibit signalling events leading to chronic pain.

[1]  Robert Langer,et al.  pH-Responsive Polymer Microspheres: Rapid Release of Encapsulated Material within the Range of Intracellular pH** , 2001 .

[2]  J. L. Brown,et al.  Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain , 1996, Neuroscience.

[3]  C. Maggi,et al.  Tachykinin receptor antagonists in clinical trials , 2009, Expert opinion on investigational drugs.

[4]  A. McCluskey,et al.  Synthesis of Dynole 34-2, Dynole 2-24 and Dyngo 4a for investigating dynamin GTPase , 2014, Nature Protocols.

[5]  Omid C Farokhzad,et al.  pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.

[6]  M. von Zastrow,et al.  GPCR signaling along the endocytic pathway. , 2014, Current opinion in cell biology.

[7]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[8]  Pierangelo Geppetti,et al.  G Protein-Coupled Receptors: Dynamic Machines for Signaling Pain and Itch , 2015, Neuron.

[9]  A. Prochiantz,et al.  Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions , 1980, Nature.

[10]  H. Maeda,et al.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[12]  Meritxell Canals,et al.  Genetically Encoded FRET Biosensors to Illuminate Compartmentalised GPCR Signalling. , 2017, Trends in pharmacological sciences.

[13]  A. Herz,et al.  Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds , 1988, Pharmacology Biochemistry and Behavior.

[14]  Robert Langer,et al.  Impact of nanotechnology on drug delivery. , 2009, ACS nano.

[15]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[16]  W. D. de Jong,et al.  Drug delivery and nanoparticles: Applications and hazards , 2008, International journal of nanomedicine.

[17]  Pierangelo Geppetti,et al.  Neurokinin 1 receptor signaling in endosomes mediates sustained nociception and is a viable therapeutic target for prolonged pain relief , 2017, Science Translational Medicine.

[18]  Pierangelo Geppetti,et al.  Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission , 2017, Proceedings of the National Academy of Sciences.

[19]  D. Schmaljohann.  Thermo- and pH-responsive polymers in drug delivery. , 2006, Advanced drug delivery reviews.

[20]  T. Pelissier,et al.  Pannexin 1: A novel participant in neuropathic pain signaling in the rat spinal cord , 2014, PAIN®.

[21]  A. Basbaum,et al.  Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. , 1995, Science.

[22]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[23]  Christopher E. Nelson,et al.  Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo. , 2013, ACS nano.

[24]  R G Hill,et al.  Distinct mechanism for antidepressant activity by blockade of central substance P receptors. , 1998, Science.

[25]  Alex R. B. Thomsen,et al.  Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors. , 2018, Trends in pharmacological sciences.

[26]  L. Villanueva,et al.  Burst-Like Subcutaneous Electrical Stimulation Induces BDNF-Mediated, Cyclotraxin B-Sensitive Central Sensitization in Rat Spinal Cord , 2018, Front. Pharmacol..

[27]  G. Cottrell,et al.  Endosomes: A legitimate platform for the signaling train , 2009, Proceedings of the National Academy of Sciences.

[28]  M. von Zastrow,et al.  Functional selectivity of GPCR-directed drug action through location bias , 2017, Nature chemical biology.

[29]  Brian L. Schmidt,et al.  Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome , 2018, Proceedings of the National Academy of Sciences.

[30]  J. Steyaert,et al.  A Genetically Encoded Biosensor Reveals Location Bias of Opioid Drug Action , 2018, Neuron.

[31]  X. Navarro,et al.  Randall-Selitto test: a new approach for the detection of neuropathic pain after spinal cord injury. , 2012, Journal of neurotrauma.

[32]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[33]  F. Caruso,et al.  Interfacing Materials Science and Biology for Drug Carrier Design , 2015, Advanced materials.

[34]  C. Woolf,et al.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.

[35]  R. Lo,et al.  A method for measurement of analgesic activity on inflamed tissue. , 1957 .

[36]  J. Aten,et al.  Measurement of co‐localization of objects in dual‐colour confocal images , 1993, Journal of microscopy.

[37]  A. Christopoulos,et al.  A Positive Allosteric Modulator of the Adenosine A1 Receptor Selectively Inhibits Primary Afferent Synaptic Transmission in a Neuropathic Pain Model , 2015, Molecular Pharmacology.

[38]  C. Pothoulakis,et al.  Tachykinins and their receptors: contributions to physiological control and the mechanisms of disease. , 2014, Physiological reviews.

[39]  Jinming Gao,et al.  Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. , 2011, Angewandte Chemie.

[40]  David E. Gloriam,et al.  Trends in GPCR drug discovery: new agents, targets and indications , 2017, Nature Reviews Drug Discovery.

[41]  Volker Haucke,et al.  Synthesis of the Pitstop family of clathrin inhibitors , 2014, Nature Protocols.

[42]  J. Vilardaga.  ENDOSOMAL GENERATION OF cAMP in GPCR SIGNALING , 2014, Nature chemical biology.

[43]  L. O. Randall,et al.  A method for measurement of analgesic activity on inflamed tissue. , 1957, Archives internationales de pharmacodynamie et de therapie.